PubRank

L T Archer

Author PubWeight™ 38.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A model for thrombin protection against endotoxin. Thromb Res 1984 1.09
2 Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg 1981 1.08
3 Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res 1980 1.07
4 Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion. J Trauma 1983 1.04
5 Prevention of death in endotoxin shock by glucose administration. Surg Gynecol Obstet 1974 1.01
6 Responses of the baboon to live Escherichia coli organisms and endotoxin. Surg Gynecol Obstet 1977 1.01
7 Effects of endotoxin on myocardial hemodynamics, performance, and metabolism. Am J Physiol 1971 1.01
8 Effects of endotoxin on myocardial hemodynamics, performance, and metabolism during beta adrenergic blockade. Proc Soc Exp Biol Med 1971 1.00
9 Effectiveness of modified steroid-antibiotic therapies for lethal sepsis in the dog. Arch Surg 1983 0.98
10 A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment. Surg Gynecol Obstet 1978 0.98
11 Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ Shock 1978 0.97
12 Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet 1979 0.96
13 Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Cancer Res 1990 0.95
14 Mechanisms of impaired cardiac function by vasopressin. Ann Surg 1980 0.95
15 Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res 1981 0.92
16 Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 1985 0.89
17 Myocardial function in shock. Am J Physiol 1974 0.85
18 Current management of the septic shock patient: experimental basis for treatment. Circ Shock 1982 0.85
19 Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment. Surg Gynecol Obstet 1978 0.85
20 Reversal of myocardial dysfunction in endotoxin shock with insulin. Can J Physiol Pharmacol 1978 0.84
21 Renal gluconeogenesis and increased glucose utilization in shock. Am J Physiol 1976 0.84
22 Increased survival with methylprednisolone treatment in canine endotoxin shock. J Surg Res 1978 0.83
23 Prevention and reversal of myocardial failure in endotoxin shock. Surg Gynecol Obstet 1973 0.81
24 Cardiac response to circulating factors in endotoxin shock. Am J Physiol 1972 0.81
25 Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 1974 0.80
26 Leukocyte response and hypoglycemia in superlethal endotoxic shock. Circ Shock 1977 0.80
27 Myocardial dysfunction in endotoxin- and E. coli-induced shock: pathophysiological mechanisms. Circ Shock 1985 0.80
28 Glucose utilization and role of blood in endotoxin shock. Am J Physiol 1977 0.79
29 Vasopressin release during sepsis and septic shock in baboons and dogs. Surg Gynecol Obstet 1981 0.79
30 Effects of prior administration of steroids upon recovery from lethal sepsis. Surg Gynecol Obstet 1986 0.79
31 Myocardial substrate utilization in dogs following endotoxin administration. Am J Physiol 1974 0.79
32 A morphologic study of live Escherichia coli organism shock in baboons. Exp Mol Pathol 1979 0.79
33 Myocardial failure with altered response to adrenaline in endotoxin shock. Br J Pharmacol 1975 0.78
34 Effects of glucose or insulin on myocardial performance in endotoxin shock. Proc Soc Exp Biol Med 1976 0.78
35 Endogenous anticoagulation during extracorporeal perfusion: generation of a heparinlike inhibitor. Am J Physiol 1980 0.78
36 Hypoglycemic response of blood to live Escherichia coli organisms and endotoxin. J Surg Res 1976 0.78
37 Extracorporeal perfusion without exogenous anticoagulation: its protective role in endotoxin shock. Circ Shock 1982 0.78
38 Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock 1981 0.78
39 Effect of endotoxin on myocardial performance. J Trauma 1972 0.77
40 Dose-response effect of in vivo administration of endotoxin on polymorphonuclear leukocytes oxidative burst. Shock 1996 0.77
41 Halothane for controlled hypotension in back surgery. Can Anaesth Soc J 1967 0.77
42 Physiopathologic responses of the rhesus monkey to live Escherichia coli. Surg Gynecol Obstet 1976 0.77
43 Comparison of Staphylococcus aureus and Escherichia coli infusion in conscious rats. J Surg Res 1994 0.77
44 Evaluation of naloxone for therapy of Escherichia coli shock. Species differences. Arch Surg 1984 0.76
45 Improvement of renal hemodynamics in endotoxin shock with dopamine, phenoxybenzamine and dextran. J Pharmacol Exp Ther 1971 0.76
46 "Iliac horn syndrome". Hereditary onycho-osteo dysplasia. A case presentation. Med Serv J Can 1965 0.76
47 The heart and endotoxin shock. Tex Rep Biol Med 1979 0.75
48 Evaluation of naloxone therapy for Escherichia coli sepsis in the baboon. Arch Surg 1988 0.75
49 Does sodium pentobarbital anesthesia compromise phagocytosis of E coli in vitro? Circ Shock 1980 0.75
50 Associated leukocyte responses in the lethal aspects of E. coli shock. Proc Soc Exp Biol Med 1977 0.75
51 Effects of coronary hypotension on myocardial substrate utilization. Am J Physiol 1975 0.75
52 Survival characteristics during septic shock in 39 baboons. Adv Shock Res 1982 0.75
53 Myocardial performance in splanchnic arterial occlusion shock. J Surg Res 1973 0.75
54 Prevention or amelioration of morphologic lesions in LD100 E coli-shocked baboons with steroid/antibiotic therapy. Adv Shock Res 1983 0.75
55 Relationship of serum gentamicin levels and methylprednisolone sodium succinate treatment in baboons challenged with Escherichia coli LD100. Clin Ther 1983 0.75
56 Does LD100 E coli shock cause myocardial failure? Circ Shock 1982 0.75
57 Effects of methylprednisolone sodium succinate on clearance of live E coli from the peripheral blood of dogs. Adv Shock Res 1979 0.75
58 Does sodium pentobarbital anesthesia compromise clearance of bacteria or survival of dogs in lethal E coli shock? Circ Shock 1981 0.75
59 Hematologic disturbances during sepsis: platelets and leukocytes. Adv Shock Res 1982 0.75
60 Preserved liver function and leukocyte response in superlethal endotoxic shock. Circ Shock 1978 0.75
61 Recovery from endotoxin shock after extracorporeal perfusion without anticoagulation. Circ Shock 1979 0.75
62 Preventing versus delaying death in shock therapy studies: evaluating "survival". Circ Shock 1983 0.75
63 Treatment of LD100 Escherichia coli septic shock with netilmicin and methylprednisolone in baboons. Med Microbiol Immunol 1986 0.75
64 Prolonged shock in the monkey following live E coli organism infusion. Circ Shock 1979 0.75
65 Extracorporeal perfusion without anticoagulation and the response to endotoxin. Surg Gynecol Obstet 1979 0.75
66 In vitro effects of methyprednisolone sodium succinate and E coli organisms on neutrophils in baboon blood. Circ Shock 1978 0.75
67 Dose-response effects of cardiac glycosides on pooling and systemic and pulmonary hemodynamics. Can J Physiol Pharmacol 1970 0.75
68 Absence of hypoglycemia in canine splanchnic arterial occlusion (SAO) shock. J Surg Res 1976 0.75
69 Tobramycin therapy for lethal sepsis in the dog. Crit Care Med 1986 0.75